Linganisha mbinu

	Maswali ya Tathmini ya Athari za Upotevu wa Nywele (ALPPQ)	cDLQI
Nyanja	Dermatolojia	Dermatolojia
Familia	Process / pipeline	Process / pipeline
Mwaka wa asili	2014	1995
Mwanzilishi	Gupta AK, Strober BE et al.	Lewis-Jones MS, Finlay AY
Aina	Self-report	Self-report (parent or child proxy)
Chanzo asilia	Gupta AK, Talukder M. Alopecia areata: autoimmune basis of hair loss and available treatment options. Can J Dermatol. 2014;12(5):289-304.	Lewis-Jones MS, Finlay AY. The Children's Dermatology Life Quality Index (cDLQI): initial validation and practical use. Br J Dermatol. 1995;132(6):942-949.
Majina mbadala	Hair Loss Impact Questionnaire, Alopecia Areata QoL	cDLQI, Pediatric DLQI
Zinazohusiana	4	3
Muhtasari	The Hair Loss Impact Questionnaire (Alopecia Areata Patient Priority Outcomes Questionnaire, ALPPQ) is a disease-specific, patient-administered quality-of-life measure assessing the psychosocial and functional burden of alopecia areata, a chronic autoimmune disorder causing patchy hair loss. Alopecia areata affects appearance, self-esteem, and social functioning disproportionately, often causing depression and anxiety. The ALPPQ captures these impacts, ensuring that treatment efficacy encompasses meaningful quality-of-life outcomes. It is increasingly used in clinical trials and observational studies of alopecia areata therapeutics.	The Children's Dermatology Life Quality Index (cDLQI) is a pediatric-adapted version of the adult DLQI, measuring the impact of skin disease on quality of life in children and adolescents aged 4–16 years. Developed by Lewis-Jones and Finlay in 1995, it uses child-friendly language and addresses domains relevant to childhood (school, leisure, friendships, clothing) rather than work and adult relationships. cDLQI is the standard quality-of-life measure in pediatric dermatology trials and clinical practice.